{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:30:33Z","timestamp":1790818233162,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T00:00:00Z","timestamp":1654992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T00:00:00Z","timestamp":1654992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s13760-022-01984-3","type":"journal-article","created":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T07:02:18Z","timestamp":1655017338000},"page":"865-869","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Eotaxin-1 (CCL11) in neuroinflammatory disorders and possible role in COVID-19 neurologic complications"],"prefix":"10.1007","volume":"122","author":[{"given":"Donya","family":"Nazarinia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5742-6537","authenticated-orcid":false,"given":"Mahin","family":"Behzadifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Gholampour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roqaye","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadali","family":"Gholampour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,12]]},"reference":[{"issue":"5","key":"1984_CR1","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3349\/ymj.2020.61.5.431","volume":"61","author":"KS Hong","year":"2020","unstructured":"Hong KS, Lee KH, Chung JH, Shin KC, Choi EY, Jin HJ et al (2020) Clinical features and outcomes of 98 patients hospitalized with SARS-CoV-2 infection in Daegu, South Korea: a brief descriptive study. Yonsei Med. J 61(5):431","journal-title":"Yonsei Med. J"},{"key":"1984_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.comppsych.2018.10.003","volume":"87","author":"SM Lee","year":"2018","unstructured":"Lee SM, Kang WS, Cho A-R, Kim T, Park JK (2018) Psychological impact of the 2015 MERS outbreak on hospital workers and quarantined hemodialysis patients. Compr Psychiatry 87:123\u2013127","journal-title":"Compr Psychiatry"},{"key":"1984_CR3","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1046\/j.1440-1843.2003.00522.x","volume":"8","author":"K Chan","year":"2003","unstructured":"Chan K, Zheng J, Mok Y, Li Y, Liu YN, Chu C et al (2003) SARS: prognosis, outcome and sequelae. Respirology 8:S36\u2013S40","journal-title":"Respirology"},{"issue":"22","key":"1984_CR4","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1001\/archinternmed.2009.384","volume":"169","author":"MH-B Lam","year":"2009","unstructured":"Lam MH-B, Wing Y-K, Yu MW-M, Leung C-M, Ma RC, Kong AP et al (2009) Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med 169(22):2142\u20137","journal-title":"Arch Intern Med"},{"issue":"4","key":"1984_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.nrleng.2020.04.002","volume":"35","author":"P Serrano-Castro","year":"2020","unstructured":"Serrano-Castro P, Estivill-Torr\u00fas G, Cabezudo-Garc\u00eda P, Reyes-Bueno J, Petersen NC, Aguilar-Castillo M et al (2020) Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic? Neurolog\u00eda (English Edition) 35(4):245\u2013251","journal-title":"Neurolog\u00eda (English Edition)"},{"issue":"1","key":"1984_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-020-00640-3","volume":"12","author":"MT Heneka","year":"2020","unstructured":"Heneka MT, Golenbock D, Latz E, Morgan D, Brown R (2020) Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimer\u2019s Res Ther 12(1):1\u20133","journal-title":"Alzheimer's Res Ther"},{"issue":"3","key":"1984_CR7","first-page":"345","volume":"39","author":"M Junhua","year":"2020","unstructured":"Junhua M, Qi Z, Xue G, Lijuan L, Zhongwen Z, Jing W (2020) Analysis of psychological and sleep state of medical stuff with novel coronavirus pneumonia. Herald Med 39(3):345\u2013349","journal-title":"Herald Med"},{"key":"1984_CR8","doi-asserted-by":"crossref","unstructured":"Go\u00ebrtz YM, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FV et al (2020) Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res 6(4).","DOI":"10.1183\/23120541.00542-2020"},{"issue":"4","key":"1984_CR9","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.biopsych.2013.06.010","volume":"75","author":"S Horv\u00e1th","year":"2014","unstructured":"Horv\u00e1th S, Mirnics K (2014) Immune system disturbances in schizophrenia. Biol Psychiat 75(4):316\u2013323","journal-title":"Biol Psychiat"},{"key":"1984_CR10","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3389\/fimmu.2021.650331","volume":"12","author":"S Gebremeskel","year":"2021","unstructured":"Gebremeskel S, Schanin J, Coyle KM, Butuci M, Luu T, Brock EC et al (2021) Mast cell and eosinophil activation are associated with COVID-19 and TLR-mediated viral inflammation: implications for an anti-siglec-8 antibody. Front Immunol 12:641","journal-title":"Front Immunol"},{"key":"1984_CR11","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/all.14983","volume":"77","author":"Y Mitamura","year":"2022","unstructured":"Mitamura Y, Schulz D, Oro S, Li N, Kolm I, Lang C et al (2022) Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID-19 patients. Allergy 77:595\u2013608","journal-title":"Allergy"},{"issue":"1","key":"1984_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaci.2020.04.021","volume":"146","author":"AW Lindsley","year":"2020","unstructured":"Lindsley AW, Schwartz JT, Rothenberg ME (2020) Eosinophil responses during COVID-19 infections and coronavirus vaccination. J Allergy Clin Immunol 146(1):1\u20137","journal-title":"J Allergy Clin Immunol"},{"issue":"7821","key":"1984_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","volume":"584","author":"C Lucas","year":"2020","unstructured":"Lucas C, Wong P, Klein J, Castro TB, Silva J, Sundaram M et al (2020) Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 584(7821):463\u2013469","journal-title":"Nature"},{"key":"1984_CR14","doi-asserted-by":"crossref","unstructured":"Lippi G, Henry BM (2020) Eosinophil count in severe coronavirus disease 2019 (COVID-19). QJM: An Int J Med 511\u2013512","DOI":"10.1093\/qjmed\/hcaa137"},{"issue":"5","key":"1984_CR15","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1096\/fj.11-200246","volume":"26","author":"R Shamri","year":"2012","unstructured":"Shamri R, Melo RC, Young KM, Bivas-Benita M, Xenakis JJ, Spencer LA et al (2012) CCL11 elicits secretion of RNases from mouse eosinophils and their cell-free granules. FASEB J 26(5):2084\u20132093","journal-title":"FASEB J"},{"issue":"11","key":"1984_CR16","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/j.1600-0854.2005.00344.x","volume":"6","author":"RC Melo","year":"2005","unstructured":"Melo RC, Spencer LA, Perez SA, Ghiran I, Dvorak AM, Weller PF (2005) Human eosinophils secrete preformed, granule-stored interleukin-4 through distinct vesicular compartments. Traffic 6(11):1047\u20131057","journal-title":"Traffic"},{"issue":"Suppl. 1","key":"1984_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000053573","volume":"117","author":"A El-Shazly","year":"1998","unstructured":"El-Shazly A, Masuyama K, Nakano K, Eura M, Samejima Y, Ishikawa T (1998) Human eotaxin induces eosinophil-derived neurotoxin release from normal human eosinophils. Int Arch Allergy Immunol 117(Suppl. 1):55\u201358","journal-title":"Int Arch Allergy Immunol"},{"issue":"5","key":"1984_CR18","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1083\/jcb.139.5.1349","volume":"139","author":"EF Foxman","year":"1997","unstructured":"Foxman EF, Campbell JJ, Butcher EC (1997) Multistep navigation and the combinatorial control of leukocyte chemotaxis. J Cell Biol 139(5):1349\u20131360","journal-title":"J Cell Biol"},{"issue":"1","key":"1984_CR19","first-page":"145","volume":"52","author":"PM Murphy","year":"2000","unstructured":"Murphy PM, Baggiolini M, Charo IF, H\u00e9bert CA, Horuk R, Matsushima K et al (2000) International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52(1):145\u201376","journal-title":"Pharmacol Rev"},{"issue":"2","key":"1984_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0092-8674(94)90337-9","volume":"76","author":"TA Springer","year":"1994","unstructured":"Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76(2):301\u2013314","journal-title":"Cell"},{"key":"1984_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.pneurobio.2013.02.001","volume":"104","author":"A R\u00e9aux-Le Goazigo","year":"2013","unstructured":"R\u00e9aux-Le Goazigo A, Van Steenwinckel J, Rost\u00e8ne W, Parsadaniantz SM (2013) Current status of chemokines in the adult CNS. Prog Neurobiol 104:67\u201392","journal-title":"Prog Neurobiol"},{"issue":"9","key":"1984_CR22","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3390\/ph13090230","volume":"13","author":"M Ivanovska","year":"2020","unstructured":"Ivanovska M, Abdi Z, Murdjeva M, Macedo D, Maes A, Maes M (2020) CCL-11 or eotaxin-1: an immune marker for ageing and accelerated ageing in neuro-psychiatric disorders. Pharmaceuticals 13(9):230","journal-title":"Pharmaceuticals"},{"issue":"3","key":"1984_CR23","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1189\/jlb.1107763","volume":"84","author":"AE Cardona","year":"2008","unstructured":"Cardona AE, Li M, Liu L, Savarin C, Ransohoff RM (2008) Chemokines in and out of the central nervous system: much more than chemotaxis and inflammation. J Leukoc Biol 84(3):587\u2013594","journal-title":"J Leukoc Biol"},{"issue":"9","key":"1984_CR24","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.3390\/ijms20092283","volume":"20","author":"VM Milenkovic","year":"2019","unstructured":"Milenkovic VM, Stanton EH, Nothdurfter C, Rupprecht R, Wetzel CH (2019) The role of chemokines in the pathophysiology of major depressive disorder. Int J Mol Sci 20(9):2283","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1984_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/nyas.12855","volume":"1351","author":"O Le Thuc","year":"2015","unstructured":"Le Thuc O, Blondeau N, Nahon JL, Rov\u00e8re C (2015) The complex contribution of chemokines to neuroinflammation: switching from beneficial to detrimental effects. Ann N Y Acad Sci 1351(1):127\u2013140","journal-title":"Ann N Y Acad Sci"},{"issue":"23","key":"1984_CR26","doi-asserted-by":"publisher","first-page":"9592","DOI":"10.1523\/JNEUROSCI.5610-12.2013","volume":"33","author":"AS Harms","year":"2013","unstructured":"Harms AS, Cao S, Rowse AL, Thome AD, Li X, Mangieri LR et al (2013) MHCII is required for \u03b1-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration. J Neurosci 33(23):9592\u20139600","journal-title":"J Neurosci"},{"issue":"4","key":"1984_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3233\/JPD-130250","volume":"3","author":"GT Kannarkat","year":"2013","unstructured":"Kannarkat GT, Boss JM, Tansey MG (2013) The role of innate and adaptive immunity in Parkinson\u2019s disease. J Parkinsons Dis 3(4):493\u2013514","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"1984_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","volume":"20","author":"CA Janeway Jr","year":"2002","unstructured":"Janeway CA Jr, Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20(1):197\u2013216","journal-title":"Annu Rev Immunol"},{"key":"1984_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.brainresbull.2019.05.020","volume":"152","author":"J-Q Liu","year":"2019","unstructured":"Liu J-Q, Chu S-F, Zhou X, Zhang D-Y, Chen N-H (2019) Role of chemokines in Parkinson\u2019s disease. Brain Res Bull 152:11\u201318","journal-title":"Brain Res Bull"},{"key":"1984_CR30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3389\/fpsyt.2018.00241","volume":"9","author":"AL Teixeira","year":"2018","unstructured":"Teixeira AL, Gama CS, Rocha NP, Teixeira MM (2018) Revisiting the role of eotaxin-1\/CCL11 in psychiatric disorders. Front Psych 9:241","journal-title":"Front Psych"},{"issue":"2","key":"1984_CR31","first-page":"124","volume":"18","author":"S Sirivichayakul","year":"2019","unstructured":"Sirivichayakul S, Kanchanatawan B, Thika S, Carvalho AF, Maes M (2019) A new schizophrenia model: immune activation is associated with the induction of different neurotoxic products which together determine memory impairments and schizophrenia symptom dimensions. CNS Neurol Disord-Drug Targets (Formerly Current Drug Targets-CNS Neurological Disorders) 18(2):124\u201340","journal-title":"CNS Neurol Disord-Drug Targets (Formerly Current Drug Targets-CNS Neurological Disorders)"},{"issue":"1","key":"1984_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-05654-w","volume":"7","author":"E Kindstedt","year":"2017","unstructured":"Kindstedt E, Holm CK, Sulniute R, Martinez-Carrasco I, Lundmark R, Lundberg P (2017) CCL11, a novel mediator of inflammatory bone resorption. Sci Rep 7(1):1\u201310","journal-title":"Sci Rep"},{"issue":"1","key":"1984_CR33","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s12640-018-9937-8","volume":"35","author":"S Sirivichayakul","year":"2019","unstructured":"Sirivichayakul S, Kanchanatawan B, Thika S, Carvalho AF, Maes M (2019) Eotaxin, an endogenous cognitive deteriorating chemokine (ECDC), is a major contributor to cognitive decline in normal people and to executive, memory, and sustained attention deficits, formal thought disorders, and psychopathology in schizophrenia patients. Neurotox Res 35(1):122\u2013138","journal-title":"Neurotox Res"},{"issue":"7362","key":"1984_CR34","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature10357","volume":"477","author":"SA Villeda","year":"2011","unstructured":"Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G et al (2011) The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477(7362):90\u201394","journal-title":"Nature"},{"issue":"6","key":"1984_CR35","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1172\/JCI5150","volume":"103","author":"TL S\u00f8rensen","year":"1999","unstructured":"S\u00f8rensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA et al (1999) Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Investig 103(6):807\u2013815","journal-title":"J Clin Investig"},{"issue":"9","key":"1984_CR36","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.psyneuen.2012.03.019","volume":"37","author":"H Eyre","year":"2012","unstructured":"Eyre H, Baune BT (2012) Neuroplastic changes in depression: a role for the immune system. Psychoneuroendocrinology 37(9):1397\u20131416","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"1984_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-11-31","volume":"11","author":"MJ Stuart","year":"2014","unstructured":"Stuart MJ, Corrigan F, Baune BT (2014) Knockout of CXCR5 increases the population of immature neural cells and decreases proliferation in the hippocampal dentate gyrus. J Neuroinflammation 11(1):1\u20139","journal-title":"J Neuroinflammation"},{"issue":"6","key":"1984_CR38","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1073\/pnas.1211270110","volume":"110","author":"K Baruch","year":"2013","unstructured":"Baruch K, Ron-Harel N, Gal H, Deczkowska A, Shifrut E, Ndifon W et al (2013) CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain aging. Proc Natl Acad Sci 110(6):2264\u20132269","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"1984_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1517\/13543784.9.1.43","volume":"9","author":"CP Bertrand","year":"2000","unstructured":"Bertrand CP, Ponath PD (2000) CCR3 blockade as a new therapy for asthma. Expert Opin Investig Drugs 9(1):43\u201352","journal-title":"Expert Opin Investig Drugs"},{"issue":"46","key":"1984_CR40","doi-asserted-by":"publisher","first-page":"42957","DOI":"10.1074\/jbc.M103933200","volume":"276","author":"R Martinelli","year":"2001","unstructured":"Martinelli R, Sabroe I, LaRosa G, Williams TJ, Pease JE (2001) The CC chemokine eotaxin (CCL11) is a partial agonist of CC chemokine receptor 2b. J Biol Chem 276(46):42957\u201342964","journal-title":"J Biol Chem"},{"key":"1984_CR41","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3389\/fncel.2018.00488","volume":"12","author":"S Bachiller","year":"2018","unstructured":"Bachiller S, Jim\u00e9nez-Ferrer I, Paulus A, Yang Y, Swanberg M, Deierborg T et al (2018) Microglia in neurological diseases: a road map to brain-disease dependent-inflammatory response. Front Cell Neurosci 12:488","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"1984_CR42","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/glia.1106","volume":"36","author":"F Aloisi","year":"2001","unstructured":"Aloisi F (2001) Immune function of microglia. Glia 36(2):165\u2013179","journal-title":"Glia"},{"issue":"2","key":"1984_CR43","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/glia.10161","volume":"40","author":"UK Hanisch","year":"2002","unstructured":"Hanisch UK (2002) Microglia as a source and target of cytokines. Glia 40(2):140\u2013155","journal-title":"Glia"},{"issue":"10","key":"1984_CR44","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1089\/ars.2011.3960","volume":"16","author":"D-H Choi","year":"2012","unstructured":"Choi D-H, Crist\u00f3v\u00e3o AC, Guhathakurta S, Lee J, Joh TH, Beal MF et al (2012) NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson\u2019s disease. Antioxid Redox Signal 16(10):1033\u20131045","journal-title":"Antioxid Redox Signal"},{"issue":"42","key":"1984_CR45","doi-asserted-by":"publisher","first-page":"14465","DOI":"10.1523\/JNEUROSCI.2246-12.2012","volume":"32","author":"AC Crist\u00f3v\u00e3o","year":"2012","unstructured":"Crist\u00f3v\u00e3o AC, Guhathakurta S, Bok E, Je G, Yoo SD, Choi D-H et al (2012) NADPH oxidase 1 mediates \u03b1-synucleinopathy in Parkinson\u2019s disease. J Neurosci 32(42):14465\u201314477","journal-title":"J Neurosci"},{"issue":"3","key":"1984_CR46","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S1471-4892(01)00044-3","volume":"1","author":"JE Pease","year":"2001","unstructured":"Pease JE, Williams TJ (2001) Eotaxin and asthma. Curr Opin Pharmacol 1(3):248\u2013253","journal-title":"Curr Opin Pharmacol"},{"issue":"12","key":"1984_CR47","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1002\/glia.22892","volume":"63","author":"B Parajuli","year":"2015","unstructured":"Parajuli B, Horiuchi H, Mizuno T, Takeuchi H, Suzumura A (2015) CCL11 enhances excitotoxic neuronal death by producing reactive oxygen species in microglia. Glia 63(12):2274\u20132284","journal-title":"Glia"},{"issue":"3","key":"1984_CR48","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1124\/jpet.114.213074","volume":"349","author":"MA Erickson","year":"2014","unstructured":"Erickson MA, Morofuji Y, Owen JB, Banks WA (2014) Rapid transport of CCL11 across the blood-brain barrier: regional variation and importance of blood cells. J Pharmacol Exp Ther 349(3):497\u2013507","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"1984_CR49","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cyto.2013.07.019","volume":"64","author":"B Michael","year":"2013","unstructured":"Michael B, Elsone L, Griffiths M, Faragher B, Borrow R, Solomon T et al (2013) Post-acute serum eosinophil and neutrophil-associated cytokine\/chemokine profile can distinguish between patients with neuromyelitis optica and multiple sclerosis; and identifies potential pathophysiological mechanisms\u2013a pilot study. Cytokine 64(1):90\u201396","journal-title":"Cytokine"},{"issue":"13","key":"1984_CR50","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1212\/01.wnl.0000326589.57128.c3","volume":"71","author":"M Tanaka","year":"2008","unstructured":"Tanaka M, Matsushita T, Tateishi T, Ochi H, Kawano Y, Mei F-J et al (2008) Distinct CSF cytokine\/chemokine profiles in atopic myelitis and other causes of myelitis. Neurology 71(13):974\u2013981","journal-title":"Neurology"},{"issue":"5","key":"1984_CR51","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1177\/1352458510392619","volume":"17","author":"J Correale","year":"2011","unstructured":"Correale J, Fiol M (2011) Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis. Mult Scler J 17(5):521\u2013531","journal-title":"Mult Scler J"},{"issue":"4","key":"1984_CR52","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1093\/brain\/awq035","volume":"133","author":"M Comabella","year":"2010","unstructured":"Comabella M, Fern\u00e1ndez M, Martin R, Rivera-Vallv\u00e9 S, Borr\u00e1s E, Chiva C et al (2010) Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis. Brain 133(4):1082\u20131093","journal-title":"Brain"},{"issue":"7","key":"1984_CR53","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/brain\/awf151","volume":"125","author":"CF Lucchinetti","year":"2002","unstructured":"Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM et al (2002) A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica. Brain 125(7):1450\u20131461","journal-title":"Brain"},{"issue":"6","key":"1984_CR54","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nm.2165","volume":"16","author":"JA Obeso","year":"2010","unstructured":"Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, Rodriguez M et al (2010) Missing pieces in the Parkinson\u2019s disease puzzle. Nat Med 16(6):653\u2013661","journal-title":"Nat Med"},{"issue":"2","key":"1984_CR55","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","volume":"120","author":"WJ Schulz-Schaeffer","year":"2010","unstructured":"Schulz-Schaeffer WJ (2010) The synaptic pathology of \u03b1-synuclein aggregation in dementia with Lewy bodies, Parkinson\u2019s disease and Parkinson\u2019s disease dementia. Acta Neuropathol 120(2):131\u2013143","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1984_CR56","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/bmb\/ldn013","volume":"86","author":"CA Davie","year":"2008","unstructured":"Davie CA (2008) A review of Parkinson\u2019s disease. Br Med Bull 86(1):109\u2013127","journal-title":"Br Med Bull"},{"key":"1984_CR57","doi-asserted-by":"publisher","first-page":"S209","DOI":"10.1016\/S1353-8020(09)70816-8","volume":"15","author":"E Hirsch","year":"2009","unstructured":"Hirsch E (2009) Iron transport in Parkinson\u2019s disease. Parkinsonism Relat Disord 15:S209\u2013S211","journal-title":"Parkinsonism Relat Disord"},{"issue":"29","key":"1984_CR58","doi-asserted-by":"publisher","first-page":"15267","DOI":"10.1074\/jbc.M116.714824","volume":"291","author":"G Chandra","year":"2016","unstructured":"Chandra G, Rangasamy SB, Roy A, Kordower JH, Pahan K (2016) Neutralization of RANTES and eotaxin prevents the loss of dopaminergic neurons in a mouse model of Parkinson disease. J Biol Chem 291(29):15267\u201315281","journal-title":"J Biol Chem"},{"key":"1984_CR59","first-page":"7","volume":"64","author":"GL Wenk","year":"2003","unstructured":"Wenk GL (2003) Neuropathologic changes in Alzheimer\u2019s disease. J Clin Psychiatry 64:7\u201310","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"1984_CR60","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/mp.2015.131","volume":"20","author":"M Lalli","year":"2015","unstructured":"Lalli M, Bettcher B, Arcila M, Garcia G, Guzman C, Madrigal L et al (2015) Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer\u2019s disease. Mol Psychiatry 20(11):1294\u20131300","journal-title":"Mol Psychiatry"},{"key":"1984_CR61","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.csbj.2021.01.034","volume":"19","author":"BA Khalil","year":"2021","unstructured":"Khalil BA, Elemam NM, Maghazachi AA (2021) Chemokines and chemokine receptors during COVID-19 infection. Comput Struct Biotechnol J 19:976\u2013988","journal-title":"Comput Struct Biotechnol J"},{"issue":"3","key":"1984_CR62","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1177\/1073858420939033","volume":"27","author":"A Oliviero","year":"2021","unstructured":"Oliviero A, de Castro F, Coperchini F, Chiovato L, Rotondi M (2021) COVID-19 pulmonary and olfactory dysfunctions: is the chemokine CXCL10 the common denominator? Neuroscientist 27(3):214\u2013221","journal-title":"Neuroscientist"},{"issue":"2","key":"1984_CR63","doi-asserted-by":"publisher","first-page":"168","DOI":"10.28982\/josam.859368","volume":"5","author":"M Katar","year":"2021","unstructured":"Katar M (2021) Could eosinophil chemotactic factor (CCL11) be a useful biomarker of Covid-19? Journal of Surgery and Medicine 5(2):168\u2013173","journal-title":"Journal of Surgery and Medicine"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-022-01984-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-022-01984-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-022-01984-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T18:15:47Z","timestamp":1658340947000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-022-01984-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,12]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1984"],"URL":"https:\/\/doi.org\/10.1007\/s13760-022-01984-3","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,12]]},"assertion":[{"value":"5 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"As the current study was a review and hypothesis, there was no ethics committee to approve the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors have consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}